                         SEQUENCE LISTING

<110>  Sanford-Burnham Medical Research Institute
       Moscat-Guillen, Jorge
       Diaz-Meco Conde, Maria Teresa
 
<120>  INFLAMMATION THERAPY USING MEKK3 INHIBITORS OR BLOCKING PEPTIDES

<130>  42256-718.601

<150>  US 61/994,996
<151>  2014-05-19

<160>  22    

<170>  PatentIn version 3.5

<210>  1
<211>  82
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  1

Gln Val Thr Leu Asn Val Thr Phe Lys Asn Glu Ile Gln Ser Phe Leu 
1               5                   10                  15      


Val Ser Asp Pro Glu Asn Thr Thr Trp Ala Asp Ile Glu Ala Met Val 
            20                  25                  30          


Lys Val Ser Phe Asp Leu Asn Thr Ile Gln Ile Lys Tyr Leu Asp Glu 
        35                  40                  45              


Glu Asn Glu Glu Val Ser Ile Asn Ser Gln Gly Glu Tyr Glu Glu Ala 
    50                  55                  60                  


Leu Lys Met Ala Val Lys Gln Gly Asn Gln Leu Gln Met Gln Val His 
65                  70                  75                  80  


Glu Gly 
        


<210>  2
<211>  100
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  2

Ser Leu Thr Val Lys Ala Tyr Leu Leu Gly Lys Glu Asp Ala Ala Arg 
1               5                   10                  15      


Glu Ile Arg Arg Phe Ser Phe Cys Cys Ser Pro Glu Pro Glu Ala Glu 
            20                  25                  30          


Ala Glu Ala Ala Ala Gly Pro Gly Pro Cys Glu Arg Leu Leu Ser Arg 
        35                  40                  45              


Val Ala Ala Leu Phe Pro Ala Leu Arg Pro Gly Gly Phe Gln Ala His 
    50                  55                  60                  


Tyr Arg Asp Glu Asp Gly Asp Leu Val Ala Phe Ser Ser Asp Glu Glu 
65                  70                  75                  80  


Leu Thr Met Ala Met Ser Tyr Val Lys Asp Asp Ile Phe Arg Ile Tyr 
                85                  90                  95      


Ile Lys Glu Lys 
            100 


<210>  3
<211>  80
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  3

Asp Val Arg Ile Lys Phe Glu His Asn Gly Glu Arg Arg Ile Ile Ala 
1               5                   10                  15      


Phe Ser Arg Pro Val Lys Tyr Glu Asp Val Glu His Lys Val Thr Thr 
            20                  25                  30          


Val Phe Gly Gln Pro Leu Asp Leu His Tyr Met Asn Asn Glu Leu Ser 
        35                  40                  45              


Ile Leu Leu Lys Asn Gln Asp Asp Leu Asp Lys Ala Ile Asp Ile Leu 
    50                  55                  60                  


Asp Arg Ser Ser Ser Met Lys Ser Leu Arg Ile Leu Leu Leu Ser Gln 
65                  70                  75                  80  


<210>  4
<211>  44
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  4

Asn Thr Ile Gln Ile Lys Tyr Leu Asp Glu Glu Asn Glu Glu Val Ser 
1               5                   10                  15      


Ile Asn Ser Gln Gly Glu Tyr Glu Glu Ala Leu Lys Met Ala Val Lys 
            20                  25                  30          


Gln Gly Asn Gln Leu Gln Met Gln Val His Glu Gly 
        35                  40                  


<210>  5
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  5

Asn Thr Ile Gln Ile Lys Tyr Leu Asp Glu Glu Asn Glu Glu Val Ser 
1               5                   10                  15      


Ile Asn Ser Gln Gly Glu Tyr Glu Glu Ala Leu Lys Met Ala Val Lys 
            20                  25                  30          


Gln Gly Asn 
        35  


<210>  6
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  6

Gln Val Thr Leu Asn Val Thr Phe Lys Asn Glu Ile Gln Ser Phe Leu 
1               5                   10                  15      


Val Ser Asp Pro Glu Asn Thr Thr Trp Ala Asp Ile Glu Ala Met Val 
            20                  25                  30          


Lys Val Ser Phe Asp Leu 
        35              


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  7

Gln Val Thr Leu Asn Val Thr Phe Lys 
1               5                   


<210>  8
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  8

Asn Glu Ile Gln Ser Phe Leu Val Ser Asp Pro Glu Asn Thr 
1               5                   10                  


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  9

Thr Trp Ala Asp Ile Glu Ala Met Val Lys Val Ser Phe Asp Leu 
1               5                   10                  15  


<210>  10
<211>  43
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  10

Pro Gly Gly Phe Gln Ala His Tyr Arg Asp Glu Asp Gly Asp Leu Val 
1               5                   10                  15      


Ala Phe Ser Ser Asp Glu Glu Leu Thr Met Ala Met Ser Tyr Val Lys 
            20                  25                  30          


Asp Asp Ile Phe Arg Ile Tyr Ile Lys Glu Lys 
        35                  40              


<210>  11
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  11

Pro Gly Gly Phe Gln Ala His Tyr Arg Asp Glu Asp Gly Asp Leu Val 
1               5                   10                  15      


Ala Phe Ser Ser Asp Glu Glu Leu Thr Met Ala Met Ser Tyr Val Lys 
            20                  25                  30          


Asp Asp 
        


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  12

Ile Phe Arg Ile Tyr Ile Lys Glu Lys 
1               5                   


<210>  13
<211>  57
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  13

Ser Leu Thr Val Lys Ala Tyr Leu Leu Gly Lys Glu Asp Ala Ala Arg 
1               5                   10                  15      


Glu Ile Arg Arg Phe Ser Phe Cys Cys Ser Pro Glu Pro Glu Ala Glu 
            20                  25                  30          


Ala Glu Ala Ala Ala Gly Pro Gly Pro Cys Glu Arg Leu Leu Ser Arg 
        35                  40                  45              


Val Ala Ala Leu Phe Pro Ala Leu Arg 
    50                  55          


<210>  14
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  14

Ser Leu Thr Val Lys Ala Tyr Leu Leu Gly Lys Glu 
1               5                   10          


<210>  15
<211>  45
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  15

Asp Ala Ala Arg Glu Ile Arg Arg Phe Ser Phe Cys Cys Ser Pro Glu 
1               5                   10                  15      


Pro Glu Ala Glu Ala Glu Ala Ala Ala Gly Pro Gly Pro Cys Glu Arg 
            20                  25                  30          


Leu Leu Ser Arg Val Ala Ala Leu Phe Pro Ala Leu Arg 
        35                  40                  45  


<210>  16
<211>  45
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  16

Gln Pro Leu Asp Leu His Tyr Met Asn Asn Glu Leu Ser Ile Leu Leu 
1               5                   10                  15      


Lys Asn Gln Asp Asp Leu Asp Lys Ala Ile Asp Ile Leu Asp Arg Ser 
            20                  25                  30          


Ser Ser Met Lys Ser Leu Arg Ile Leu Leu Leu Ser Gln 
        35                  40                  45  


<210>  17
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  17

Gln Pro Leu Asp Leu His Tyr Met Asn Asn Glu Leu Ser Ile Leu Leu 
1               5                   10                  15      


Lys Asn Gln Asp Asp Leu Asp Lys Ala Ile Asp Ile Leu Asp Arg Ser 
            20                  25                  30          


Ser Ser Met Lys 
        35      


<210>  18
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  18

Ser Leu Arg Ile Leu Leu Leu Ser Gln 
1               5                   


<210>  19
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  19

Asp Val Arg Ile Lys Phe Glu His Asn Gly Glu Arg Arg Ile Ile Ala 
1               5                   10                  15      


Phe Ser Arg Pro Val Lys Tyr Glu Asp Val Glu His Lys Val Thr Thr 
            20                  25                  30          


Val Phe Gly 
        35  


<210>  20
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  20

Asp Val Arg Ile Lys Phe Glu His Asn Gly 
1               5                   10  


<210>  21
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  21

Glu Arg Arg Ile Ile Ala Phe Ser Arg Pro Val 
1               5                   10      


<210>  22
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  22

Lys Tyr Glu Asp Val Glu His Lys Val Thr Thr Val Phe Gly 
1               5                   10                  


